She received her B.S. in 2008 from the University of Maryland in Baltimore County where she was a Meyerhoff Scholar and later enrolled at the University of North Carolina at Chapel Hill, where she obtained her Ph.D. in Microbiology and Immunology in 2014. Prior to her most recent successful endeavor, her research focused on the development of a universal influenza vaccine. In addition, she has 15 years of expertise studying dengue virus, respiratory syncytial virus, and coronaviruses.
The Moderna vaccine is a messenger RNA (mRNA) vaccine. This is a new type of vaccine to protect against infectious diseases. These MRNA vaccines are designed to instruct our cells how to make proteins designed to prompt an immune response inside our bodies. Although novel, they have been looked at before to tackle other infectious diseases, including but not limited to: Zika and rabies.
The Moderna vaccine requires lipids to help deliver the mRNA to the cells, mainly 1,2-dimyristoyl-rac- glycero3-methoxypolyethylene glycol-2000 and 1,2-distearoyl-snglycero-3-phosphocholine.
Although there are some side effects, most are mild to moderate. Yet, a small number of people had severe side effects that affected their ability to do daily activities. Dr. Corbett has demonstrated that merit and competence, not race or gender, are paramount for success in America, especially in the field of science.
Without question, she should be a household name equally noted with the likes of George Washington Carver, Percy Julian and Alice Ball. It is our duty to make sure this is a certainty and not a possibility.
—torrance stephens is an infectious disease scientist. His essays can be found at https://torrancestephensphd.substack.com
